- Comparative effi cacy and safety of monoclonal antibodies in rheumatoid arthritis
Gabriela Kot, Łukasz Świątek, Dorota Sikorska, Włodzimierz Samborski
- Aducanumab in Alzheimer’s disease: effi cacy and controversies
Dominik Lewandowski, Mateusz Konieczny, Wojciech Kozubski, Jolanta Dorszewska
- Advances in the treatment of neurodegenerative diseases and the role of the clinical pharmacist in interdisciplinary patient care
Małgorzata Kołtun-Jasion, Marta Baranowska-Kuczko
- Changes in the pharmacokinetics of antibacterial drugs in obesity – part 2
Aleksandra Pawska, Konrad Sarnowski, Daria Bayraktar, Sandra Mazurkiewicz, Józef Muszyński, Katarzyna Wawrzyniak, Olga Stanisławowska, Marta Świder, Weronika Ziętkiewicz, Gabriela Brzozowska, Oliwia Kleybor, Danuta Szkutnik-Fiedler
- Intravenous and subcutaneous immunoglobulins for therapeutic use
Judyta Lachowicz, Aleksandra Spodymek
- Ticagrelor – the mechanism of action and use in patients with Coronary Artery Disease (CAD)
Milena Seweryn, Marcin Grabowski
- Gastrointestinal complications after using inosine pranobex in child – case report and literature review
Katarzyna Korzeniowska
- Gastrointestinal complications after using oseltamivir in pregnant women – case report and literature review
Katarzyna Korzeniowska
- Spondylodiscitis as a complication of Staphylococcal bacteremia. Rational antibiotic therapy as an optimal therapeutic approach – a case report
Tomasz Musiała, Katarzyna Leszczyńska, Wiktor Urbański
